High Definition Breast Tomosynthesis
Trust in what you see – at the widest angle.

High Definition Breast Tomosynthesis
DBT Screening Trial

What experts say

Learn how your colleagues benefit from this technology.

Why the angle makes the difference – get more clinical proof!

Dr. Wayne Lemish, Melbourne, Australia is an expert in breast imaging with experience in the clinical use of different tomosynthesis systems. Hear how a self-created phantom with alphabet cookies can provide a simple but effective demonstration of the image quality from different systems.

Case 1 - Comparison of 15° and 50° tomosynthesis

  • 55 year old woman
  • Palpable lump in the upper inner quadrant of the left breast
  • Invasive ductal carcinoma grade 2

Case 2 - Comparison of 15° and 50° tomosynthesis

  • 57 year old woman
  • Previous history of cysts and benign microcalcification
  • Infiltrating ductal carcinoma grade 3

Case 3 - Comparison of 15° and 50° tomosynthesis

  • 51 year old woman
  • Finding in 2016 (wide angle). Not seen in 2015 (narrow angle), but was visible in 2013 (wide angle)
  • Benign nodule


Insight into EMPIRE Technology

Detlev Uhlenbrock
Dortmund, Germany

“EMPIRE technology produces a significantly improved image quality, especially for microcalc and smaller lesions .”


Insight into EMPIRE Technology

Merete Christophersen, Radiographer
Rigshospitalet, Denmark

“I’m full of praise for the implant program in the new software – it’s brilliant that it changes the exposure settings automatically. We would like to have this function on all systems.”


Study about True Breast Tomosynthesis

Malmö Breast Tomosynthesis Study reveals: True Breast Tomosynthesis from Siemens increases breast cancer detection rate by 43%
Tomosynthesis detects 43% more breast cancers than traditional mammography - according to a major screening study conducted in Malmö, Sweden by the Lund University, using Siemens Healthineers’ Mammomat Inspiration system.

Experiences from the Malmö Breast Tomosynthesis Screening Trial

Dr. Kristina Lång Malmö, Sweden
Watch this recorded presentation to learn the latest on the Malmö screeining trial with up to 43% increase in breast cancer detection rate.

High Definition Breast Tomosynthesis is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

EMPIRE Technology, Insight 2D and Insight 3D are not commercially available. Due to regulatory reasons their future availability cannot be guaranteed.